In the current study, okadaic acid inhibited STAT3 serine dephosphorylation induced by pasireotide (Figure 6) suggesting that this analog can act through phosphatase 2A in pituitary tumor cells carrying the FGFR4-R388 SNP. The gene discussed is STAT3; the disease is pituitary tumor.